Lisa Cook sues Trump over firing attempt, emergency hearing set
Figs Inc (NYSE:FIGS). stock has reached a new 52-week high, touching 7.05 USD, marking a significant milestone for the healthcare apparel company. The company, now valued at $1.15 billion, maintains impressive gross profit margins of 67% and demonstrates strong financial health with a current ratio of 5.02, according to InvestingPro data. Over the past year, Figs stock has experienced a notable increase, with a total return of 24.86%. This upward trend reflects the company’s resilience and growth in the competitive market, with recent momentum showing a strong 10.53% gain in just the past week. The stock’s positive trajectory, combined with InvestingPro’s analysis suggesting slight undervaluation, points to potential further gains as the company expands its reach and strengthens its brand presence. Discover 12 additional exclusive ProTips and comprehensive valuation metrics with an InvestingPro subscription.
In other recent news, Figs Inc. reported its second-quarter 2025 earnings, surpassing Wall Street expectations with a diluted earnings per share of $0.04, doubling the forecast of $0.02. The company also exceeded revenue predictions, posting $152.6 million against an anticipated $144.17 million. Barclays (LON:BARC) responded to these strong results by raising its price target for Figs to $7.00 from $5.00, while maintaining an Equalweight rating. Similarly, BofA Securities increased its price target on Figs to $5.20 from $4.80, despite maintaining an Underperform rating. BofA Securities also adjusted its 2025 and 2026 EBITDA forecasts for Figs, increasing them by 18% and 11% to $49.2 million and $51.0 million, respectively. These adjustments reflect Figs’ updated sales and EBITDA margin guidance. These developments highlight analysts’ responses to Figs’ robust financial performance in the recent quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.